The PKA Iα reg inhibitors encompass a diverse array of chemicals strategically selected to modulate the activity of PKA Iα reg, a critical enzyme involved in cellular signaling cascades. H-89, a potent PKA inhibitor, directly interferes with PKA Iα reg by competing for the ATP-binding site, blocking its activation and subsequently impeding downstream signaling pathways regulated by PKA Iα reg. Similarly, KT5720, another PKA inhibitor, directly targets the ATP-binding site of PKA Iα reg, disrupting its catalytic activity and leading to the inhibition of downstream pathways. PKI (5-24) amide, a PKA inhibitor peptide, mimics the substrate and directly competes for the active site of PKA Iα reg, hampering its catalytic activity and disrupting downstream signaling cascades. Rp-cAMPS, a cAMP analog, acts as a competitive antagonist, indirectly inhibiting PKA Iα reg by blocking cAMP binding and subsequent activation. This interference results in the inhibition of downstream pathways regulated by PKA Iα reg.
KT5823, a PKG inhibitor, indirectly modulates PKA Iα reg by disrupting the cGMP-dependent pathway, leading to reduced PKA Iα reg activation and subsequent inhibition of downstream signaling cascades. RpcAMPS, another cAMP analog, acts as a competitive antagonist, blocking cAMP binding and indirectly inhibiting PKA Iα reg. H-8, a PKA inhibitor, directly targets the ATP-binding site of PKA Iα reg, hindering its catalytic activity and disrupting downstream signaling cascades. Myristoylated PKI, a PKA inhibitor peptide, directly competes for the active site of PKA Iα reg, disrupting its catalytic activity and inhibiting downstream signaling cascades. St-Ht31, a PKC inhibitor peptide, indirectly inhibits PKA Iα reg by disrupting the PKC pathway, leading to reduced PKA Iα reg activation and subsequent inhibition of downstream signaling cascades. Collectively, these PKA Iα reg inhibitors offer a sophisticated approach to modulating cellular signaling, providing valuable tools for researchers investigating the intricacies of PKA Iα reg function and its role in various physiological and pathological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
KT5720, a PKA inhibitor, directly inhibits PKA Iα reg by targeting the ATP-binding site, disrupting its catalytic activity. This interference results in the inhibition of downstream pathways regulated by PKA Iα reg. | ||||||
PKA Inhibitor IV | 99534-03-9 | sc-3010 | 0.5 mg | $97.00 | 17 | |
PKA Inhibitor IV directly inhibits PKA Iα reg by mimicking the substrate and competing for the active site, impeding its catalytic activity. This interference disrupts downstream signaling cascades regulated by PKA Iα reg. | ||||||
Rp-cAMPS | 151837-09-1 | sc-24010 | 1 mg | $203.00 | 37 | |
Rp-cAMPS, a cAMP analog, indirectly inhibits PKA Iα reg by acting as a competitive antagonist for cAMP binding. This prevents the activation of PKA Iα reg, leading to the inhibition of downstream pathways regulated by PKA Iα reg. | ||||||
PKI (6-22) amide | 121932-06-7 | sc-201160 | 1 mg | $160.00 | 11 | |
PKI (6-22) amide, a PKA inhibitor peptide, directly inhibits PKA Iα reg by mimicking the substrate and competitively binding to the active site, disrupting its catalytic activity. This interference hampers downstream signaling cascades regulated by PKA Iα reg. | ||||||
KT5823 | 126643-37-6 | sc-3534 sc-3534A sc-3534B | 100 µg 1 mg 5 mg | $182.00 $1228.00 $4895.00 | 21 | |
KT5823, a PKG inhibitor, indirectly inhibits PKA Iα reg by disrupting the cGMP-dependent pathway, leading to reduced PKA Iα reg activation. This interference results in the inhibition of downstream signaling cascades regulated by PKA Iα reg. | ||||||
H-8 • 2HCL | 113276-94-1 | sc-200526 sc-200526A | 10 mg 50 mg | $60.00 $250.00 | 3 | |
H-8 • 2HCl directly inhibits PKA Iα reg by competing for the ATP-binding site, hindering its catalytic activity. This interference disrupts downstream signaling cascades regulated by PKA Iα reg. | ||||||
PKI (14-22) amide (myristoylated) | 201422-03-9 | sc-471154 | 0.5 mg | $135.00 | 2 | |
Myristoylated PKI, a PKA inhibitor peptide, directly inhibits PKA Iα reg by mimicking the substrate and competitively binding to the active site, disrupting its catalytic activity. This interference disrupts downstream signaling cascades regulated by PKA Iα reg. | ||||||